Floatz logo

NEOMYCIN

Surgery--Complications

Helsinki University Central HospitalmixturePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Surgery--Complications cohort.

Asset / SponsorPhaseRating
MACROGOLS
Helsinki University Central Hospital
Phase 4BB
SUFENTANYL
Peking University First Hospital
Phase 4BB
METRONIDAZOLE
Helsinki University Central Hospital
Phase 4BB
DEXAMETHASONE
Peking University First Hospital
Phase 4BB
Flurbiprofen Axetil
Peking University First Hospital
Phase 4CCC

View all 9 →

Same molecule, other indications

NEOMYCIN is also rated in:

Surgical Site InfectionDormant
BBB
Indicative ·
72 / 100
View asset →
Rectum NeoplasmDormant
BB
Indicative ·
65 / 100
View asset →
Cetuximab-induced Papulopustular (Acneiform) Rash Who HaveDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →